Search For "covaxin"
Covaxin row: Bharat Biotech clarifies allegations over volunteer who died
Updated : 5 years, 2 months ago IST
New Delhi [India], January 9 (ANI): After a participant who allegedly died days after volunteering for Covaxin trial in Bhopal, Bharat Biotech on Saturday clarified that the volunteer, at the time of enrolment, had fulfilled all the inclusion and exclusion criteria to be accepted as a partic
Read More
India to start COVID-19 vaccination drive from January 16, healthcare, fro
Updated : 5 years, 2 months ago IST
New Delhi [India], January 9 (ANI): The COVID-19 vaccination drive in the country will start from January 16.
Read More
Ecuador envoy takes part in Covaxin trials, says Indian vaccines safe, con
Updated : 5 years, 2 months ago IST
New Delhi [India], January 8 (ANI): After taking the first shot of Covaxin, Ecuador's Envoy to India Hector Cueva Jacome on Friday said that Bharat Biotech and Serum Institute are good companies, adding that he talked to researchers in US and Ecuador and then took part in the trials.
Read More
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin phase-3 clin
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 7 (ANI): The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials of its indigenously manufactured COVID-19 vaccine 'Covaxin.'
Read More
COVID-19 vaccines 'Covishield', 'Covaxin' to be available soon in India
Updated : 5 years, 2 months ago IST
New Delhi [India], January 7 (ANI): Union Health Minister Dr Harsh Vardhan on Thursday said that the COVID-19 vaccines 'Covishield' and 'Covaxin' are on the verge of being available in the country.
Read More
Approval of Covaxin a milestone for Indian vaccinology : Karnataka Health
Updated : 5 years, 2 months ago IST
Bengaluru (Karnataka) [India], January 5 (ANI): Karnataka Health Minister Dr K Sudhakar lauded the approval of Bharat Biotech's COVID vaccine 'Covaxin' today and called it a significant milestone in India's indigenous novel vaccinology.
Read More
Bharat Biotech MD questions experts' silence over UK trials of Covid-19 va
Updated : 5 years, 2 months ago IST
New Delhi [India], January 4 (ANI): Coming down heavily on critics expressing doubts about the Bharat Biotech's indigenously developed coronavirus vaccine COVAXIN, the Hyderabad-based biotech major's managing director Dr Krishna Ella on Monday slammed the critics for targeting Indian clinica
Read More
Our goal is to provide global access of Covaxin to needy population: Dr E
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 4 (ANI): The emergency use approval for Covaxin is "a giant leap for innovation and novel product development" in India and the "goal is to provide global access to populations that need it the most", Bharat Biotech chairman and managing director Dr
Read More
Covaxin is 200% safe, says Bharat Biotech Chairman
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 4 (ANI): Covaxin, the indigenous vaccine developed by Bharat Biotech against COVID-19 in collaboration with ICMR, is 200 per cent safe, company's Chairman and Managing Director Dr Krishna Ella has said and noted that it has shown less than 10 per cen
Read More
Unseemly haste risks jeopardising India's good reputation: Shashi Tharoor
Updated : 5 years, 2 months ago IST
New Delhi [India], January 4 (ANI): A day after Union Civil Aviation Minister Hardeep Singh Puri called Shashi Tharoor a cynic for criticising the Drugs Controller General of India's (DCGI) approval of COVAXIN for "restricted use in an emergency situation" without this COVID-19 vaccine havin
Read More
Indian companies do not deserve this backlash, Covaxin is simple two doses
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 4 (ANI): Bharat Biotech Chairman and Managing Director Dr Krishna Ella said on Monday that the company has tremendous experience in vaccines, takes science seriously and Covaxin is simple two doses.
Read More
COVAXIN's approval is for emergency situation, not emergency use authorisa
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria on Sunday clarified that approval of COVAXIN, Bharat Biotech's COVID-19 vaccine is for an emergency situation and not emergency use authorisation which is given to Serum Institute
Read More